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A Xenopus oocyte expression<o-injection system was used to study the mfluence of guanine nucleotides on b-glucose uptake. GTP analogs like 
GTPyS and GppNHp had no effect on 3-O-methylglucose transport determmed by zero-trans uptake or equilibrium exchange, but suppressed 
2-deoxyglucose uptake mto Glut1 glucose transporter-expressing oocytes by up to 86%. Both GTP analogs showed concentration dependence of 
then effectiveness, with GTPyS being more potent than GppNHp. No stattstically significant dtfferences were observed between groups of oocytes 
co-injected with water or GDP@ (250 and 500pM intracellular concentration). Glut1 transporter expression in plasma membrane was not different 
between water or GTPyS-co-injected oocytes. Thus, inhibitton of hexokinase catalytic activity is the most hkely causative factor for down-regulation 
of 2-deoxyglucose uptake. 
Guanine nucleotide; Glut1 glucose transporter; Xenopus oocyte 
1. INTRODUCTION 
Molecular cloning has led to the identification of six 
different glucose transporters of the facilitative diffu- 
sion type named GLUTl-GLUTS, and Glut7 (re- 
viewed in [1,2]). The glucose transporters have been 
expressed in Xenopus laevis oocytes by injection of 
mRNA made from the cDNAs under the control of the 
bacteriophage SP6 or T7 promoter, as reviewed in [3,4]. 
This expression system has proved to be extremely use- 
ful in addressing the question of transport kinetics of 
individual glucose transporter isoforms [5-81 and in 
testing their activity after substitution of single amino 
acid residues [9,10]. In addition, the cytoplasm of 
oocytes can be altered by microinjection of substrates 
or proteins in order to study the regulatory response to 
such perturbation. 
Results from different experimental approaches indi- 
cate that guanine nucleotide-binding proteins regulate 
glucose uptake in adipocytes and muscle cells [l l-181. 
Baldini et al. [18], confirmed by Robinson et al. [19], 
reported that non-hydrolyzable GTP analogs exert an 
insulin-like effect on translocation of glucose trans- 
porter to the plasma membrane in permeabilized adi- 
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pocytes. These data, however, left open the question of 
whether the intrinsic activity of the glucose transporter 
is altered. Since Xenopus oocytes are ideally suited to 
study the function of the heterologously expressed glu- 
cose transporter, Glut1 (i.e. the HepG2/erythrocyte 
type, [5-7,9,10]), we used this system to evaluate a puta- 
tive involvement of GTP nucleotides in glucose uptake 
regulation. Since permeabilization of cells excludes 
transport measurements for this purpose, GTP analogs 
were applied by microinjection into Xenopus oocytes 
after prior injection and translation of the in vitro syn- 
thesized mRNA of Glut 1. 
2. EXPERIMENTAL 
2.1. Preparatron of and injection into oocytes 
Collectton, defolliculation and culture of Xenopus oocytes were con- 
ducted as described previously [4,6,9,10]. The XbaI-linearized oocyte 
expression vector, pSP64T, containing the Glut1 cDNA under the 
control of the bacteriophage promoter, SP6, was used for transcrip- 
tion. Routinely, oocytes were injected with 50 nl of a solution contain- 
ing capped (‘“‘GpppG) mRNA at a concentration of 1 mg/ml. Healthy 
looking oocytes were collected after 3 days for co-injection of the 
indicated nucleotides. pH-adJusted aqueous solutions of GTPyS, 
GDPBS, GppNHp, and water as control, were mtcroinjected through 
glass capillartes 60 min before 2-deoxyglucose or 3-O-methylglucose 
uptake measurements, and plasma membrane isolation. From previ- 
ous eqmlibration experiments with labeled 3-O-methylglucose, the 
water space per oocyte was calculated to be about 0.5 ,LLI [6]. The 
respective nucleotide-containing solutions were adJusted such that a 
microinjection of 25 nl of the respective nucleottde resulted in mtracel- 
lular levels of 500, 250, 125, 62.5, and 31.25 ,uM. 
2.2. Uptakeltransport measurement and detection of GlutI expression 
Three days after injection of water (sham group), or mRNAs (Glut1 
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group), nucleotide solutions or water were co-Injected mto oocytes 
Usually. 8-10 single oocytes of each group were taken for glucose 
uptake/transport measurement. The uptake assay consisted of “C- 
labeled 2-deoxyglucose or 3-O-methylglucose (50flM, 1 ,&i/ml) in 0.5 
ml of modified Barths’ solution (MBS) at room temperature. “C- 
Labeled 3-O-methylglucose transport assay was also conducted under 
equlhbrium exchange influx conditions with M&S containing IO mM 
3-O-methylglucose. To test for transport mhlbitlon. uptake was also 
conducted m the presence of 20 PM cytochalasin B (CB). After the 
Indicated periods of time the oocytes were washed 3 times with 3 ml 
of ice-cold MBS containing 0.1 mM phloretm (i.e. stop solution). Each 
single oocyte was dissolved in 0.5 ml of 1% SDS before quantification 
of radloactlvity by a liquid scintillation spectrophotometer. 
In order to Isolate oocyte plasma membranes. single oocytes of the 
sham group (A), the Glut1 group after water injection (B), and the 
Glut I group after GTPyS co-injection (500 PM mtracellular concen- 
tration) (C) were trlturated m Barths’ modified solution (MBS) by use 
of an adjustable IO ~1 Eppendorf pipette [6]. For Western dotblot 
analysis, these ghosts were further treated as described previously 
[6,9]. Nitrocellulose membranes (Hybond-C, Amersham Buchler. 
Braunschweig. Germany) were loaded with 5 and 40 pg. respectively. 
of protein from the sham group and the Glut1 groups. A purified 
transporter (a kmd gift from Dr. Gustav Lienhard. Dartmouth Med- 
ical School. Hanover, NH, USA) was used as standard. The detection 
system consisted of an IgG fraction from a rabbit antiserum raised 
against a synthetic peptlde (F350) and of “‘I-labeled protein A (1.5 
mCi/ml). 
Maxlmum activity of hexokmase was determined spectrophotomet- 
rlcally according to Bergmeyer [20]. The reaction was started with the 
addition of IO0 ~1 of the 100,000 x g supernatant of oocyte homoge- 
nate. Inhibition of the catalytic activity by GTPyS was tested after 
addition of GTPyS-contamlng solutions leading to the same final 
concentrations as used for oocyte co-injection (see above). Values were 
presented as the percentage of uninhlblted catalytic activity. ATP was 
determined according to Adams [20]. 
2.4. Muter~al.5 
All substrates used were of the highest grade quality. The nucleo- 
tide5 were purchased from Boehrmger-Mannhelm GmbH, Germany; 
cytochalasin B and phloretm from Sigma Chemicals, St. Louis. MO. 
USA: [“‘IJprotein A and Hybond-C from Amersham Buchler. Braun- 
schwelg. Germany. XPnuplu lueplv frogs were obtained from H. 
Kghler. Xenopus Laborzucht. Hamburg, Germany. 
3. RESULTS 
Fig. 1A shows that mRNA, which had been in vitro 
transcribed from Glut1 cDNA, translated a function- 
ally active glucose transporter protein, as documented 
by the 2-deoxyglucose uptake data. Co-injection of the 
poorly hydrolyzable GTP analog GTPyS into Glutl- 
expressing oocytes suppressed the uptake by more than 
85% at 500 AM intracellular concentration. The re- 
corded uptake was further suppressed by cytochalasin 
B (CB). Periods of time longer than 1 h after co-injec- 
tion were not used because of morphological changes of 
the oocytes, as judged by light microscopy. Since 
oocytes from different experiments do not necessarily 
express the same amount of glucose transporter pro- 
teins, comparison between various nucleotides was per- 
formed on a percentage basis, with Glut1 glucose trans- 
porter activity measured in the absence of nucleotides 
set to 100% (Fig. 1 B). The non-hydrolyzable GTP ana- 
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Fig. I. I-Deoxyglucose uptake into Glut1 mRNA-InJected oocytes IS 
inhibited by GTP analogs. (A) Oocytes were injected with 50 nl of 
water (sham) or mRNA-contammg solution (Glut I ). Three days after 
injection. oocytes were co-inJected with 25 nl of water or GTPyS 
(intracellular concentration 500 PM) 60 mm before uptake measure- 
ment. 2-Deoxyglucosc uptake for 30 mm was determined m the ab- 
sence and presence of 20pM cytochalasm B (CB). respectively Values 
represent the mean t S.E.M. of data from 7-8 oocytes. except for the 
CB groups that each include&S oocytes (B) Glutl-expressing oocqtes 
were co-injected with various concentrations of the indicated nucleo- 
tide analogs, i.e. GTPyS, GDPBS, and GppNHp. 60 mm before 3- 
deoxyglucose uptake measurement. Based on the assumption of an 
average oocyte volume of 0.5 ~1, InJection of 25 nl of nucleotlde- 
contaming solutions led to the mdlcated mtracellular concentrations. 
Since these data were from two Independent experiments Z-deoxyglu- 
case uptake of the water-injected Glut l-expressing groups was set to 
100% m order to mutually compare the effectiveness of the tested 
nucleotides. Intracellular concentrations after co-injection were: (a) 
62 5, (b) 125, (c) 250, and (d) 500 ,uM 
log, GppNHp, was a less effective inhibitor compared 
to GTPyS, whereas co-injection of GDPPS, a metabol- 
ically stable GDP analog leading to intracellular con- 
centrations of 250 and 500 ,uM was without effect. 
To determine whether the inhibition of glucose up- 
take in Glut 1 glucose transporter-expressing oocytes by 
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Fig. 2. GTPyS does not affect 3-O-methylglucose transport. Groups 
of S--l0 oocytes were used to measure “C-labeled 3-U-methylglucose 
transport into oocytes at the indtcated periods of time under zero-trcIl?s 
(A) and equilibrium exchange Influx condtttons (B) The equi~ibratlng 
concentration was 10 mM 3-~-mcthylglucose. Glutl-expressing 
oocytes were co-injected with either 25 nl of water or GTPyS-contain- 
ing solution (intracellular concentration 500 ,uM) about 60 min before 
transport measurement. Stop of transport was achieved exactly as 
described for 2-deoxyglucose uptake Values represent the 
mean + S.E.M. 
GTPyS was due to a direct effect on the catalytic activ- 
ity of the transporter, we complemented the data with 
14C-labeled 3-O-methylglucose transport measure- 
ments. GTP analogs may down-regulate the glucose 
transporting system by influencing hexokinase activity, 
rendering it the rate-limiting step of glucose uptake, 
and/or could affect intracellular ATP necessary for 2- 
deoxyglucose phosphorylation. Fig. 2 compares the in- 
tracellular accumulation of 14C-labeled 3-O-methylglu- 
case under zero-trans (Fig. 2A, for time periods up to 
1 min) and equilibrium exchange influx conditions (Fig. 
2B, for 1-15 min) in Glutl-expressing oocytes between 
the water-injected group and GTPyS-treated cells. The 
data indicate that 3-O-methylglucose uptake/exchange 
at different periods of time was not affected by GTPyS, 
even at its highest concentration, thus definitely exclud- 
ing a direct GTP or a G-protein-mediated effect on 
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Fig. 3. Inhibition of hexokmase activrty by GTPyS. Herokinase activ- 
ity of a 100,000 x g supernatant from oocyte homogenate was deter- 
mined accordmg to Bergmeyer [20] and tested for mhibttion by 
GTPyS at the Indicated concentrations. The maximum catalytic actrv- 
ity of non-injected oocytes amounted to 0.38 pm01 converted o-glu- 
coseloocytelmm and was set to 100%. 
Glut1 transporter function. ATP levels tested in sham 
oocytes, Glut1 water-injected, and Glut1 GTPyS-co- 
injected oocytes did not differ significantly (2.8,2.8, and 
2.5 mM, respectively); however, GTPyS (Fig. 3), used 
at the same concentrations as for co-injection, strongly 
inhibited hexokinase activity from the 100,000 x g su- 
pernatant of oocyte homogenate. Since uptake of D- 
glucose includes transport and phosphorylation, the 
concentration-dependent inhibition of hexokinase ac- 
tivity was the most likely cause for down-regulation of 
2-deoxyglucose uptake. 
Fig. 4 demonstrates that, at least during 60 min post- 
injection, effects on translocation of glucose transporter 
molecules were not involved in the GTP inhibition of 
Glut 1 -mediated uptake. Plasma membranes isolated 
from Glutl-expressing oocytes that had been co-in- 
jected with either water or GTPyS (intracellular concen- 
tration 500 PM) exhibited identical signals on the im- 
munoblot. Ahquots of purified erythrocyte glucose 
transporter were used as standards and plasma mem- 
branes of sham-injected oocytes served as negative con- 
trols. 
4. DISCUSSION 
Xenoptts oocytes have been reported to possess a G- 
protein system that appears to be involved in various 
cellular responses [21,22]. Here they are used as a con- 
venient ~xpression~o-injection system for the study of 
effector-mediated influence on glucose transporter ac- 
tivity. G-proteins, as transducers of receptor signals, 
have been proposed to be involved in the counter-regu- 
latory actions on glucose transporter intrinsic activity 
by /3-adrenergic receptor agonists like isoproterenol. 
For many systems like the G-protein-regulated adenyl- 
ate cyclase system 123,241, non-hydrolyzable or poorly 
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Fig. 4, CiTpyS co-mjection does not alter the amount of Glut1 &cose 
transporter expressed m plasma membrane. Western dotblot analysis 
was performed from plasma membranes of sham-Injected (A, control) 
and mRNA-injected oocytes after co-injection of 25 nl of either water 
(B) or GTPyS-containing sohuron (C). For details of plasma mem- 
brane isolation and Western blot analysts see section 2. 5 and 40 gug 
of protein were loaded on the nitrocetlulose membrane and compared 
with aliquots (i.e. 50 ng, 10 ng, and 5 ng) of purifted glucose trans- 
porter CD). 
hydrolyzable analogs appear to be more effective than 
GTP itself, which is readily metabolized. Data are pre- 
sented that after injection of Ghrtf mRNA into oocytes 
the intrinsic activity of the Glut1 glucose transporter 
was not affected by GTP analogs such as GTPyS and 
GppNHp, whereas the uptake of 2-deoxyglucose was 
decreased in a concentration-dependent manner. Con- 
sistent with reports from other systems [25]_ GTP@ was 
a mom powerful tool than the imido analog, GppNHp. 
GDP/IS co-injection, used at the two highest concentra- 
tions chosen (i.e. 250 and 500pM), served as a standard 
indicator for an exclusive GTP involvement in glucose 
uptake regulation. 
As reported recently [25,27], translocation might be 
involved in the increase of n-glucose uptake after treat- 
ment of oocytes with insulin. Although Xenopus oocytes 
possess functional insulin-like growth factor-l receptors 
on their surface, we (unpublished observations) and 
others [7f were unable to detect an effect of insulin on 
glucose uptake. The rest&s in Fig. 4 argue against an 
inhibitory effect of GTP nucleotides on transfocation as 
a possible mechanism for 2-deoxyglucose transport 
down-regulation. Thus, by co-injection of GTP analogs 
into oocytes a putative signal transduction towards the 
catalytic activity of the transport protein should be de- 
tectable. Since nucleotide-co-injected oocytes exhibit 
normal ATP levels, the inhibition of hexokinase by 
GTP analogs most hkely contributes to the observed 
effect. This excludes a direct GTP-mediated effect on 
the transport function of Glut 1, at least after its expres- 
sion in the plasma membrane of Xelzuyus oocytes. 
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